Trial NCT03729245

View at ClinicalTrials.gov 
Org. Study IDs: 17-214-09
Secondary IDs: CA045002

Last trial update was posted on 2023-04-11

MeSH Interventions

Nivolumab Sunitinib

MeSH Conditions

Carcinoma Carcinoma, Renal Cell

Other Conditions

Metastatic Renal Cell Carcinoma Renal Cell Carcinoma

Stopping Reasons

Sponsor decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID